Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept”

Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept”

Saved in:

Bibliographic Details
Main Authors:	Mariana P. Miranda-Hernández, Carlos A. López-Morales, Francisco C. Perdomo-Abúndez, Rodolfo D. Salazar-Flores, Nancy D. Ramírez-Ibanez, Nestor O. Pérez, Aaron Molina-Pérez, Jorge Revilla-Beltri, Emilio Medina-Rivero, Luis F. Flores-Ortiz
Format:	Article
Language:	English
Published:	Wiley 2018-01-01
Series:	Journal of Immunology Research
Online Access:	http://dx.doi.org/10.1155/2018/6156024
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Assessment of Physicochemical Properties of Rituximab Related to Its Immunomodulatory Activity
by: Mariana P. Miranda-Hernández, et al.
Published: (2015-01-01)

Acute Q Fever in an Ankylosing Spondyloarthritis Patient Treated with Etanercept
by: A. Guiga, et al.
Published: (2021-01-01)

Relapsing Polychondritis in a Patient with Ankylosing Spondylitis Using Etanercept
by: Valderilio Feijó Azevedo, et al.
Published: (2014-01-01)

Perceptions of Biosimilars Among Healthcare Providers in Saudi Arabia
by: Mohammed Alqahtani, et al.
Published: (2024-11-01)

Inefficacy or Paradoxical Effect? Uveitis in Ankylosing Spondylitis Treated with Etanercept
by: Bernd Raffeiner, et al.
Published: (2014-01-01)

Etanercept-Induced Pityriasis Lichenoides Chronica in a Patient with Rheumatoid Arthritis
by: Andrés F. Echeverri, et al.
Published: (2015-01-01)

Comment on “Clinical and Pathological Characteristics of Autoimmune Hepatitis with Acute Presentation”
by: Paolo Muratori
Published: (2020-01-01)

Confidence Region Approach for Assessing Bioequivalence and Biosimilarity Accounting for Heterogeneity of Variability
by: Jianghao Li, et al.
Published: (2015-01-01)

IS IT POSSIBLE TO USE BEVACIZUMAB BIOSIMILAR IN ALL INDICATIONS REGISTERED FOR ORIGINAL DRUG?
by: S. V. Orlov, et al.
Published: (2016-06-01)

Acute Generalized Exanthematous Pustulosis Induced by Etanercept: Another Dermatologic Adverse Effect
by: Mukaddes Kavala, et al.
Published: (2013-01-01)

A Rare Association of Autoimmune Hemolytic Anemia with Gastric Adenocarcinoma
by: Kavita Agrawal, et al.
Published: (2017-01-01)

Response to: Comment on “Clinical and Pathological Characteristics of Autoimmune Hepatitis with Acute Presentation”
by: Yi Shen, et al.
Published: (2021-01-01)

Clinical Outcomes and Patient Experience of Biosimilar to Biosimilar Infliximab Switching in Patients with Inflammatory Bowel Disease: A Prospective, Single-Centre, Phase IV Interventional Study with a Nested Qualitative Study
by: Clare Harris, et al.
Published: (2023-01-01)

Inhibition of tumour necrosis factor alpha by Etanercept attenuates Shiga toxin-induced brain pathology
by: Robin Christ, et al.
Published: (2025-02-01)

Intertoe Squamous Cell Carcinoma Developed in a Patient with Rheumatoid Arthritis under Etanercept Therapy
by: Efstathios Rallis, et al.
Published: (2015-01-01)

Lung Sarcoidosis in Etanercept Treated Rheumatoid Arthritis Patient: A Case Report and Review of the Literature
by: Supat Thongpooswan, et al.
Published: (2014-01-01)

Successful treatment of etanercept- and adalimumab-resistant pyoderma gangrenosum with spesolimab, moderate-dose corticosteroids, and minocycline
by: Hanlin Zhang, et al.
Published: (2025-12-01)

Clinical Outcomes in Patients Receiving Originator Follitropin Alfa and Follitropin Alfa Biosimilars in Real-world Clinical Practice: A Retrospective Study
by: Nayana Hitesh Patel, et al.
Published: (2023-04-01)

No impact of seronegativity on the efficacy of a biosimilar rituximab in biologic-naïve patients with active rheumatoid arthritis
by: Nedumooli Pottammal Jamshid, et al.
Published: (2019-01-01)

Role of biosimilar introduction on insulin glargine prices: a retrospective analysis in 28 European countries
by: David Beran, et al.
Published: (2025-01-01)

Effect of the Addition of Essential Oils and Functional Extracts of Clove on Physicochemical Properties of Chitosan-Based Films
by: Paola Reyes-Chaparro, et al.
Published: (2015-01-01)

Effects of infliximab biosimilar on retinal microvasculature in Crohn’s disease patients evaluated by optical coherence tomography angiography
by: Hesham M. El Mazar, et al.
Published: (2025-01-01)

Affordable mRNA Novel Proteins, Recombinant Protein Conversions, and Biosimilars—Advice to Developers and Regulatory Agencies
by: Sarfaraz K. Niazi
Published: (2025-01-01)

Understanding Community Pharmacists’ Knowledge, Attitudes, and Practices Regarding Biosimilar Drugs: A Cross-Sectional Survey
by: Anan S. Jarab, et al.
Published: (2025-01-01)

L’Arbre colonne de Kitayama : comment passer d’une ressource matérielle à un paysage culturel ?
by: Benoît Jacquet, et al.
Published: (2021-05-01)

Etanercept Attenuates Traumatic Brain Injury in Rats by Reducing Brain TNF-α Contents and by Stimulating Newly Formed Neurogenesis
by: Chong-Un Cheong, et al.
Published: (2013-01-01)

Giant Cell Myocarditis in a Patient With Crohn's Disease, Treated with Etanercept – A Tumour Necrosis Factor-Alpha Antagonist
by: C Nash, et al.
Published: (2001-01-01)

Etanercept Suppresses Arteritis in a Murine Model of Kawasaki Disease: A Comparative Study Involving Different Biological Agents
by: Ryuji Ohashi, et al.
Published: (2013-01-01)

Knowledge on the Use of Biosimilars in Hematological Malignancies Amongst Health Care Workers at a Tertiary Hospital in Northeast Nigeria
by: Rufai A. Dachi, et al.
Published: (2024-07-01)

Innovator ranibizumab ComparEd to Biosimilar ranibizumab in combination with Expansile gas in submaculaR HemorrhaGe: the ICEBERG study
by: Debdulal Chakraborty, et al.
Published: (2025-01-01)

Rheumatoid Arthritis and Autoimmune Hemolytic Anemia as First Manifestation of Rhupus
by: Alejandra Espinosa-Orantes, et al.
Published: (2020-01-01)

A retrospective cohort study of biosimilar rituximab therapy in pemphigus: experience from a tertiary care hospital in North India
by: Sabha Mushtaq, et al.
Published: (2024-11-01)

Suppression of Performance Curve Instability of an Axial-Flow Pump by Using a Double-Inlet-Nozzle
by: P. Pérez Flores, et al.
Published: (2008-01-01)

Treatment journey in rheumatoid arthritis with biosimilars: from better access to good disease control through cost savings and prevention of nocebo effects
by: Bruno Fautrel, et al.
Published: (2021-06-01)

Attenuation of Autoimmune Phenomena in a Patient with Autoimmune Polyglandular Syndrome Type 1
by: Jill D. Jacobson, et al.
Published: (2021-01-01)

Systemic Lupus Erythematosus and Systemic Autoimmune Connective Tissue Disorders behind Recurrent Diastolic Heart Failure
by: Luis Miguel Blasco Mata, et al.
Published: (2012-01-01)

Serum drug levels and anti-drug antibodies in the context of dose tapering by interval prolongation of adalimumab, etanercept and ustekinumab in psoriasis patients: results of the CONDOR trial
by: Selma Atalay, et al.
Published: (2022-07-01)

Erratum: Clinical Outcomes in Patients Receiving Originator Follitropin Alfa and Follitropin Alfa Biosimilars in Real-world Clinical Practice: A Retrospective Study
Published: (2023-07-01)

Estimación de las constantes elásticas del terreno en el área de Salazar, Estado de México, a través de exploración sísmica
by: Jesús Hernán Flores, et al.
Published: (2000-01-01)

Physicochemical Characterization of Representative Firewood Species Used for Cooking in Some Colombian Regions
by: Hernán E. Díez, et al.
Published: (2017-01-01)